Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifamycin Sodium Injection

Approval Number

国药准字H51024010

Company成都第一制药有限公司

Registration Date

April 21, 2021

Previous Approval Numbers

国药准字H51024010

Drug Information

Generic Name

利福霉素钠注射液

Dosage Form

注射剂(注射液)

Strength

2ml:0.125g(12.5万单位)

Drug Type

化学药品

Registration Date

April 21, 2021

Company Information

Applicant Company

Company Name成都第一制药有限公司

Company Address

四川省彭州市天彭镇东三环路二段133号

Manufacturing Company

Company Name成都第一制药有限公司

Company Address

四川省彭州市天彭镇东三环路二段133号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利福霉素钠注射液 - NMPA 批准文号 | MedPath